Structure and Recognition of a Novel HIV-1 gp120-gp41 Interface Antibody that Caused MPER Exposure through Viral Escape.

Wibmer CK, Gorman J, Ozorowski G, Bhiman JN, Sheward DJ, Elliott DH, Rouelle J, Smira A, Joyce MG, Ndabambi N, Druz A, Asokan M, Burton DR, Connors M, Abdool Karim SS, Mascola JR, Robinson JE, Ward AB, Williamson C, Kwong PD, Morris L, Moore PL.
PLOS Pathogens 2017 January 13(1): e1006074.

Read publication
Microbial genome-wide association studies: lessons from human GWAS.

Power RA, Parkhill J, de Oliveira T.
Nature Reviews Genetics 2017; 18(1):41-50.

Read publication
The dynamics of HIV transmission in out of school young heterosexual men in South Africa: a systematic scoping review protocol.

Ntombela N, Mashamba-Thompson TP, Mtshali A, Voce A, Kharsany AB.
Systematic Reviews 2017; 6(1):9.

Read publication
Space-time migration patterns and risk of HIV acquisition in rural South Africa.

Dobra A, Bärnighausen T, Vandormael A, Tanser F.
AIDS 2017; 31(1):137-145.

Read publication
Effect of Antiretroviral Therapy on the Memory and Activation Profiles of B Cells in HIV-Infected African Women.

Tanko RF, Soares AP, Müller TL, Garrett NJ, Samsunder N, Abdool Karim Q, Abdool Karim SS, Riou C, Burgers WA.
Journal of Immunology 2017; 198(3):1220-1228.

Read publication
Early evolution of HLA-associated escape mutations in variable Gag proteins predicts CD4+ decline in HIV-1 subtype C infected women.

Chopera DR, Ntale R, Ndabambi N, Garrett N, Gray CM, Matten D, Abdool Karim Q, Abdool Karim SS, Williamson C.
AIDS 2017; 31(2):191-197.

Read publication

Centre for the AIDS Programme of Research in South Africa

CAPRISA was created in 2001 and formally established in 2002 under the NIH-funded Comprehensive International Program of Research on AIDS (CIPRA) by five partner institutions; University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute for Communicable Diseases, and Columbia University in New York. CAPRISA is a designated UNAIDS Collaborating Centre for HIV Prevention Research. The main goal of CAPRISA is to undertake globally relevant and locally responsive research that contributes to understanding HIV pathogenesis, prevention and epidemiology as well as the links between tuberculosis and AIDS care.